Prediction of barrett's esophagus among men

American Journal of Gastroenterology

Volumn 108, Issue 3, 2013, Pages 353-362

  Rubenstein, Joel H ^a,b   Morgenstern, Hal ^c   Appelman, Henry ^b   Scheiman, James ^b   Schoenfeld, Philip ^a,b   McMahon, Laurence F ^b   Metko, Valbona ^b   Near, Ellen ^b   Kellenberg, Joan ^b   Kalish, Tal ^b   Inadomi, John M ^d  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGE; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SMOKING; WAIST HIP RATIO;

AGE FACTORS; AGED; BARRETT ESOPHAGUS; CROSS-SECTIONAL STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SMOKING; WAIST-HIP RATIO;

EID: 84875231770     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.446     Document Type: Article

References (42)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassifi cation in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-6.
2. Taylor JB, Rubenstein JH. Meta-analyses of the effect of symptoms of gastroesophageal reflux on risk of Barrett's esophagus. Am J Gastroenterol 2010; 105: 1730-7.
3. Rubenstein JH, Taylor JB. Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther 2010; 32: 1222-7.
4. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-95.
5. Spechler SJ, Sharma P, Souza RF et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011; 140: 1084-91.
6. Chey WD, Inadomi JM, Booher AM et al. Primary-care physicians'perceptions and practices on the management of GERD: results of a national survey. Am J Gastroenterol 2005; 100: 1237-42.
7. Hirota W, Zuckerman M, Adler D et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006; 63: 570-80.
8. Spechler SJ, Sharma P, Souza RF et al. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011; 140: e18-52; quiz-e13.
9. Whiteman DC, Sadeghi S, Pandeya N et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57: 173-80.
10. Vaughan TL, Davis S, Kristal A et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4: 85-92.
11. Wang KK, Sampliner RE, Practice Parameters Committee of the American College of G. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103: 788-97.
12. National Health and Nutrition Examination Survey: Anthropometry Procedures Manual: Centers for Disease Control, 2004
13. Varia I, Logue E, O'Connor C et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000; 140: 367-72.
14. Peghini PL, Katz PO, Castell DO. Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998; 42: 807-13.
15. Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-9.
16. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classifi cation. Gut 1999; 45: 172-80.
17. Locke GR, Talley NJ, Weaver AL et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clinic Proceedings 1994; 69: 539-47.
18. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 2003; 58: 661-70.
19. Vakil N, van Zanten SV, Kahrilas P et al. The Montreal defi nition and classifi cation of gastroesophageal reflux disease: a global evidence-based consensus. A J Gastroenterol 2006; 101: 1900-20; quiz-1943.
20. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115: 928-35.
21. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassifi cation and beyond. Statist Med 2008; 27: 157-72; discussion 207-12.
22. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassifi cation measures. Ann Intern Med 2009; 150: 795-802.
23. Ward EM, Wolfsen HC, Achem SR et al. Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol 2006; 101: 12-7.
24. Rex DK, Cummings OW, Shaw M et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003; 125: 1670-7.
25. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7.
26. Zagari RM, Fuccio L, Wallander MA et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 2008; 57: 1354-9.
27. Ronkainen J, Aro P, Storskrubb T et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129: 1825-31.
28. Edelstein ZR, Farrow DC, Bronner MP et al. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007; 133: 403-11.
29. Smith KJ, O'Brien SM, Smithers BM, et al., for the Study of Digestive H. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2005; 14: 2481-6.
30. Conio M, Filiberti R, Blanchi S, et al., Gruppo Operativo per lo Studio delle Precancerosi E. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer 2002; 97: 225-9.
31. Gerson LB, Edson R, Lavori PW et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 2001; 96: 2005-12.
32. Seeff LC, Richards TB, Shapiro JA et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 2004; 127: 1670-7.
33. Sonnenberg A, Amorosi SL, Lacey MJ et al. Patterns of endoscopy in the United States: analysis of data from the centers for medicare and medicaid services and the national endoscopic database. Gastrointest Endosc 2008; 67: 489-96.
34. Rubenstein JH, Inadomi JM, Brill JV et al. Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy. Clin Gastroenterol Hepatol 2007; 5: 312-8.
35. Cooper GS, Kou TD, Chak A. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol 2009; 104-1356.
36. Rubenstein JH, Mattek N, Eisen G. Age- and sex-specific yield of Barrett's esophagus by endoscopy indication. Gastrointest Endosc 2010; 71: 21-7.
37. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170-patients followed 4.8 years. Am J Gastroenterol 1997; 92: 212-5.
38. Caygill CP, Reed PI, Johnston BJ et al. A single centre's 20 years'experience of columnar-lined (Barrett's) oesophagus diagnosis. Eur J Gastroenterol Hepatol 1999; 11: 1355-8.
39. Spechler SJ, Robbins AH, Rubins HB et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984; 87: 927-33.
40. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-9.
41. Williamson WA, Ellis Jr FH, Gibb SP et al Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151: 2212-6.
42. Dent J, Bremner CG, Collen MJ et al. Barrett's oesophagus. J Gastroenterol Hepatol 1991; 6: 1-22.